US FDA: Eli Lilly diet pill Zepbound is in short supply

Breakings ·  Apr 4 00:48
The US Food and Drug Administration (FDA) released news that Eli Lilly's diet drug Zepbound was in short supply in April, after patients, doctors, and pharmacists complained that it was difficult to obtain this drug.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment